Triple your efficiency: one overhead stirrer & 3 x temperature-controlled screening reactions

Asynt announce that lab-favourite, the DrySyn Vortex Parallel Overhead Stirring System is now available with active temperature control.

TRYP THERAPEUTICS AND EXOPHARM LIMITED ANNOUNCE COMPLETION OF PLAN OF ARRANGEMENT – Biotech Investments

, 05/01/2024 / 15:53, EST/EDT – EQS Newswire – Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange,

May 2, 2024

4DMT secures rare paediatric designation for cystic fibrosis gene therapy – Pharmaceutical Technology

Share this article Around 40,000 children and adults in the US alone live with the disease that causes severe damage to the lungs. Image credit:

January 24, 2024

Self-reported symptom screening reduces symptom burden in pediatric cancer patients

Regular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients with cancer, according to new research led

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.